medigraphic.com
ISSN 1025-0255 (Electronic)

2016, Number 6

<< Back Next >>

AMC 2016; 20 (6)

Surveillance of the effectiveness and safety of the VALERGEN vaccines in the treatment of asthma

Pagés RC, Calderín MO, Morales MM

Language: Spanish
References: 31
Page: 636-647
PDF size: 764.96 Kb.


ABSTRACT

Background: immunotherapy is the sole therapeutic strategy used to change the direction of physiopathology of allergic illnesses, hence the importance of this study, its application, the possible adverse reactions and its effectiveness in these conditions.
Objective: to evaluate the effectiveness and safety of the VALERGEN vaccines in the treatment of asthma.
Methods: an observational study of cohort was carried out in patients with diagnosis of mild to moderate persistent and intermittent asthma on which the administration of the VALERGEN vaccines were indicated by sublingual route or subcutaneously. An active prospective approach of the patients with asthma was used and the method of pharmacosurveillance monitoring of adverse events in a cohort was established. A sample of 100 patients fulfilling the selection criteria was conformed. The data were gathered through questionnaires. The analysis of data was done using descriptive and inferential statistics. The prosecution of information was carried out by means of the statistical package SPSS version 15.0. The obtained results were illustrated in charts and graphics.
Results: A prevalence of patient with decreased asthma symptoms was found and also the need for medication with the use of immunotherapy, this result that showed a high statistical significance (p=0,000). The adverse events presented more often were, the weal › 5cm, erythema, rhinitis and the rhinitis association and asthma, these prevailed in the ages from 5 to 9 years, feminine sex, subcutaneous route, with the mixture of Dermatophagoides pteronyssinus and Blomia tropicalis (VALERGEN DP + VALERGEN BT) and with concentration of 20 000 UB/ml.
Conclusion: immunotherapy with VALERGEN vaccines provides a positive clinical evolution in the majority of the patients, with a low rate of adverse events which confirms its effectiveness and safety in the treatment of asthma.


REFERENCES

  1. Álvarez Castelló M, Castro Almarales RL, Labrada Rosado A, Enríquez Domínguez I, Ronquillo Díaz M, Ronquillo M, et al. Prescripción y Vigilancia de la inmunoterapia sublingual con vacunas estandarizadas de ácaros domésticos en un servicio de alergología. VacciMonitor [Internet]. 2012 [citado 3 Feb 2014];21(3):[aprox. 4 p.]. Disponible en: http://www.finlay.sld.cu/publicaciones/vaccimonitor/Vm2012/a18.pdf

  2. Saranz RJ, Lozano A, Cáceres ME, Arnolt RG, Máspero JF, Bozzola CM, et al. Inmunoterapia con alergenos para la prevención y el tratamiento de las enfermedades alérgicas respiratorias de la infancia. Argentina: Sociedad Argentina de Pediatría; 2010. Arch Argent Pediatr [Internet]. May-Jun 2010 [citado 3 Feb 2014];108(3):[aprox. 2 p.]. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-00752010000300020

  3. Meadows A, Kaambwa B, Novielli N, Huissoon A, Fry-Smith A, Meads C, et al. A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis.Health Technol Assess. 2013;17(27):1-322.

  4. Lockey R, Ledford DK. Allergens and Allergen Immunotherapy. Clinical Allergy and Immunology. 4ª ed. New York: Healthcare; 2008.

  5. Calderon M, Cardona V, Demoly P. One hundred years of allergen immunotherapy European Academy of Allergy and Clinical Immunology celebration: review of unanswered questions. Allergy [Internet]. 2012 [citado 2013 May 10];67(4):[about 15 p.]. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1398-9995.2012.02785.x/pdf

  6. Larenas Linnemann D, Pereira C, Rodríguez Pérez N. Mecanismos de inmunoterapia. En: Méndez de Inocencio J, Huerta López J, Bellanti JA, Ovilla Martínez R, Escobar Gutiérrez A, editores. Alergia: Enfermedad Multisistémica. Fundamentos básicos y clínicos. México: Editorial Panamericana; 2008. p. 395-401.

  7. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev. 2003;(4):CD001186.

  8. Burks AW, Calderon MA, Casale T, Cox L, Demoly P, Jutel M, et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus. J Allergy Clin Immunol. 2013 May;131(5):1288-96.

  9. Van Ree R. Indoor allergens: Relevance of major allergen measurements and standardization. J Allergy Clin Immunol. 2007 Feb;119(2):270-7.

  10. Berto P, Frati F, Incorvaia C. Economic Studies of immunotherapy: a review. Curr Op Allergy Clin Immunol. 2008 Dec;8(6):585-9.

  11. Nasser S, Vestenbaek U, Beriot-Mathiot A, Poulsen PB. Cost effectiveness of specific immunotherapy with Grazx in allergic rhinitis co-existing with asthma. Allergy. 2008 Dec;63(12):1624-9.

  12. Edwin EA, Ronmark E, Wickens K, Perzanowski M, Barry D, Lundback B, et al. Contribution of dust mite and cat specific IgE to total IgE: Relevance to asthma prevalence. J Allergy Clin Immunol. 2007 Feb;119(2):359-65.

  13. Platts-Mills TA. The role of Indoor Allergens in chronic allergic disease. J Allergy Clin Immunol. 2007 Feb;119(2):297-302.

  14. Ferrándiz R, Casas R, Dreborg S. Sensitisation to Dermatophagoides siboney, Blomia tropicalis, and other domestic mites in asthmatic patients. Allergy [Internet]. 1996 [citado 2012 May 30];51(7):[about 11 p.]. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1398-9995.1996.tb04656.x/pdf

  15. Castro Almarales RL, Mateo Morejón M, Naranjo Robalino RM, Navarro Viltre BI, Álvarez Castelló M, Ronquillo Díaz M, et al. Correlation between skin tests to Dermatophagoides pteronyssinus, Dermatophagoides siboney and Blomia tropicalis in Cuban asthmatics. Allergol Immunopathol (Madr). 2006 Jan-Feb;34(1):23-6.

  16. Inmunoterapia. Avances del primer estudio nacional de Farmacovigilancia en inmunoterapia [Internet]. La Habana: Inmunoterapia; 2012 [citado 3 Feb 2014]. Disponible en: http://articulos.sld.cu/inmunoterapia/category/nacionales

  17. Labrada Rosado A. Desarrollo a ciclo completo de las primeras vacunas estandarizadas de alergenos de ácaros para la inmunoterapia en Cuba. [tesis doctoral]. La Habana: Instituto Superior de Ciencias Médicas; 2009.

  18. Keles S, Karakoc Aydiner E, Ozen A, Izgi AG, Tevetoglu A, Akkoc T, et al. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes. J Allergy Clin Immunol. 2011 Oct;128(4):808-15.

  19. Passalacqua G, Canonica GW. Specific immunotherapy in asthma: efficacy and safety. Clin Experimen Allerg [Internet]. 2011 [citado 2014 Feb 3];41(9):[about 7 p.]. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2222.2010.03688.x/full

  20. Kopp MV. Role of immunmodulators in allergen-specific immunotherapy. Germany Allergy [Internet]. 2011 [citado 2013 Feb 3];66(9):[about 7 p.]. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1398-9995.2011.02553.x/pdf

  21. Wayne T. House dust allergy and immunotherapy. Hum Vaccin Immunother [Internet]. 2012 Oct 1 [citado 2013 Oct 15];8(10):[about 10 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660285

  22. Capella A, Durham S. Allergen immunotherapy for allergic respiratory diseases. Hum Vaccin Immunother [Internet]. 2012 Oct 1 [citado 2013 Oct 15];8(10):[about 12 p.]. Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660772

  23. Díaz Rodríguez A, Labrada Rosado A, Castro Almarales RL, Álvarez Castelló M. Current status and future perspectives of immunotherapy in Latin America and Cuba. WAOJ [Internet]. 2014 [citado 2014 Oct 21];7(1):[about 4 p.]. Available from: http://www.waojournal.org/content/pdf/1939-4551-7-28.pdf

  24. Kim JM, Lin SY, Suárez-Cuervo C, Chelladurai Y, Ramanathan M, Segal JB, Erekosima N. Allergen-Specific Immunotherapy for Pediatric Asthma and Rhinoconjunctivitis: A Systematic Review. Pediatrics [Internet]. 2013 Jun [citado 2013 Oct 15];131(6):[about 11 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074663

  25. Jutel M. Allergen-Specific Immunotherapy in Asthma. Curr Treat Options Allergy [Internet]. 2014 Mar [citado 2014 Jun 10];1(2):[about 9 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032467/.

  26. Young-Yuen Wu A. Immunotherapy - Vaccines for allergic diseases. J Thorac Dis [Internet]. 2012 Apr 1 [citado 2013 Feb 3];4(2):[about 8 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378232

  27. Castro Almarales RL, Álvarez Castello M, Ronquillo Díaz M, González León M, Labrada Rosado A, Rodríguez Canosa JS, et al. Immunotherapy –2072. Therapeutic effect and higher safety profile for allergic asthma in Cuban patients with sublingual immunmotherapy using tropical domestic mite allergen vaccines. WAOJ [Internet]. 2013 [citado 2014 Ene 10];6(Suppl 1):[about 4 p.]. Available from: http://www.waojournal.org/content/pdf/1939-4551-6-S1-P154.pdf

  28. Castro Almarales RL, Ronquillo Díaz M, Álvarez Castello M, González León M, Labrada Rosado A, Rodríguez Canosa JS, et al. Immunotherapy – 2073. Therapeutic effect of mite allergen vaccines by subcutaneous route in allergic Cuban asthmatic patients. WAOJ [Internet]. 2013 [citado 2014 Ene 10];6(Suppl 1):[about 5 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643624/.

  29. Sugrañes Montalván A, Hernández Veiga M, Morales Menéndez M, Barreto Suárez E, Sugrañes Montalbán A, Ramírez Torres A. Uso de vacuna Valergen DP en la rinitis alérgica. AMC [Internet]. Jul-Ago 2011 [citado 3 Feb 2013];15(4):[aprox. 7 p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S1025-02552011000400005&script=sci_arttext

  30. Calderón MA, Linneberg A, Kleine Tebbe J, De Blay F, Hernandez Fernandez de Rojas D, Virchow JC, et al. Respiratory allergy caused by house dust mites: What do we really know? J Allergy Clin Immunol. 2015 Jul;136(1):38-48.

  31. Canonica GW, Cox L, Pawankar R, Baena Cagnani CE, Blaiss M, Bonini S, et al. Sublingual immunotherapy: World Allergy Organization position paper 2013 update. WAOJ [Internet]. 2014 Mar 28 [citado 2014 May 10];7(1):[about 6 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983904




2020     |     www.medigraphic.com